NorthRock Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Buy |
22,705
+2,650
| +13% | +$207K | 0.05% | 145 |
|
|
2025
Q1 | $1.45M | Sell |
20,055
-42
| -0.2% | -$3.04K | 0.05% | 153 |
|
|
2024
Q4 | $1.49M | Buy |
20,097
+2,040
| +11% | +$151K | 0.05% | 149 |
|
|
2024
Q3 | $1.19M | Sell |
18,057
-1,991
| -10% | -$131K | 0.04% | 193 |
|
|
2024
Q2 | $1.85M | Buy |
20,048
+757
| +4% | +$69.9K | 0.07% | 119 |
|
|
2024
Q1 | $1.84M | Buy |
19,291
+640
| +3% | +$61.2K | 0.07% | 129 |
|
|
2023
Q4 | $1.42M | Buy |
18,651
+5,149
| +38% | +$393K | 0.06% | 147 |
|
|
2023
Q3 | $935K | Sell |
13,502
-1,154
| -8% | -$79.9K | 0.1% | 101 |
|
|
2023
Q2 | $1.38M | Sell |
14,656
-527
| -3% | -$49.7K | 0.15% | 64 |
|
|
2023
Q1 | $1.26M | Buy |
15,183
+958
| +7% | +$79.3K | 0.13% | 73 |
|
|
2022
Q4 | $1.06M | Sell |
14,225
-1,220
| -8% | -$91K | 0.12% | 87 |
|
|
2022
Q3 | $1.28M | Sell |
15,445
-595
| -4% | -$49.2K | 0.15% | 69 |
|
|
2022
Q2 | $1.53M | Buy |
16,040
+1,753
| +12% | +$167K | 0.16% | 70 |
|
|
2022
Q1 | $1.68M | Sell |
14,287
-2,757
| -16% | -$325K | 0.15% | 66 |
|
|
2021
Q4 | $2.21M | Buy |
17,044
+383
| +2% | +$49.6K | 0.17% | 54 |
|
|
2021
Q3 | $1.89M | Buy |
16,661
+824
| +5% | +$93.3K | 0.15% | 59 |
|
|
2021
Q2 | $1.64M | Sell |
15,837
-1,346
| -8% | -$139K | 0.14% | 59 |
|
|
2021
Q1 | $1.44M | Sell |
17,183
-168
| -1% | -$14.1K | 0.13% | 63 |
|
|
2020
Q4 | $1.58M | Sell |
17,351
-1,442
| -8% | -$132K | 0.16% | 58 |
|
|
2020
Q3 | $1.5M | Buy |
18,793
+243
| +1% | +$19.4K | 0.17% | 57 |
|
|
2020
Q2 | $1.28M | Sell |
18,550
-134
| -0.7% | -$9.26K | 0.15% | 65 |
|
|
2020
Q1 | $1.18M | Sell |
18,684
-321
| -2% | -$20.2K | 0.16% | 68 |
|
|
2019
Q4 | $1.48M | Buy |
19,005
+2,328
| +14% | +$181K | 0.16% | 80 |
|
|
2019
Q3 | $1.22M | Buy |
+16,677
| New | +$1.22M | 0.17% | 81 |
|